Tradewinds Global Investors’s GSK GSK Stock Holding History

Tradewinds Global Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.95M	Sell	36,114 -254,244	-88%	-$13.9M	2.39%	18
2016 Q2	$15.7M	Sell	290,358 -12,417	-4%	-$654K	1.02%	35
2016 Q1	$15.3M	Sell	302,775 -10,128	-3%	-$504K	0.93%	42
2015 Q4	$15.8M	Sell	312,903 -13,060	-4%	-$666K	0.93%	40
2015 Q3	$15.7M	Sell	325,963 -5,508	-2%	-$287K	0.77%	45
2015 Q2	$17.3M	Buy	331,471 +25,927	+8%	+$1.46M	0.75%	50
2015 Q1	$8.75M	Sell	305,544 -103,108	-25%	-$5.91M	0.35%	69
2014 Q4	$21.8M	Sell	408,652 -27,882	-6%	-$1.56M	0.89%	39
2014 Q3	$25.1M	Sell	436,534 -11,731	-3%	-$719K	0.93%	43
2014 Q2	$30M	Sell	448,265 -25,846	-5%	-$1.75M	1.02%	43
2014 Q1	$31.7M	Sell	474,111 -43,961	-8%	-$2.97M	0.79%	42
2013 Q4	$34.6M	Buy	518,072 +84,558	+20%	+$5.48M	0.86%	37
2013 Q3	$27.2M	Sell	433,514 -260,776	-38%	-$16.8M	0.72%	43
2013 Q2	$43.4M	Buy	+694,290	New	+$44.1M	1.3%	29

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Tradewinds Global Investors's GSK Position: Q3 2016 in Review

Tradewinds Global Investors reduced its GSK (GSK) stake by 88% in Q3 2016, selling an estimated $13.9M and leaving 36,114 shares worth $1.95M. The position accounts for 2.39% of the portfolio, ranked #18.

Tradewinds Global Investors first reported a position in GSK in Q2 2013 and has held it in 14 quarters since. The position peaked at $43.4M in Q2 2013. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Tradewinds Global Investors held 36,114 shares of GSK worth $1.95M as of Q3 2016.
Tradewinds Global Investors sold 254,244 GSK shares in Q3 2016, an estimated $13.9M.
GSK made up 2.39% of Tradewinds Global Investors's portfolio in Q3 2016, its #18 holding.
Tradewinds Global Investors first reported a position in GSK in Q2 2013 and has held it in 14 quarters since.
Tradewinds Global Investors's GSK position peaked at $43.4M in Q2 2013.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Tradewinds Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.